296 related articles for article (PubMed ID: 28440909)
1. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
Yoshimatsu Y; Nakahara T; Tanaka K; Inagawa Y; Narisawa-Saito M; Yugawa T; Ohno SI; Fujita M; Nakagama H; Kiyono T
Cancer Sci; 2017 Jul; 108(7):1303-1309. PubMed ID: 28440909
[TBL] [Abstract][Full Text] [Related]
2. Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.
Choi M; Lee S; Choi T; Lee C
Virus Genes; 2014 Apr; 48(2):224-32. PubMed ID: 24293186
[TBL] [Abstract][Full Text] [Related]
3. Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes.
Muench P; Hiller T; Probst S; Florea AM; Stubenrauch F; Iftner T
Virology; 2009 May; 387(2):380-7. PubMed ID: 19285702
[TBL] [Abstract][Full Text] [Related]
4. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
5. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
Watson RA; Thomas M; Banks L; Roberts S
J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
[TBL] [Abstract][Full Text] [Related]
6. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
7. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
Nagasaka K; Kawana K; Osuga Y; Fujii T
Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
[TBL] [Abstract][Full Text] [Related]
8. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.
Accardi R; Rubino R; Scalise M; Gheit T; Shahzad N; Thomas M; Banks L; Indiveri C; Sylla BS; Cardone RA; Reshkin SJ; Tommasino M
J Virol; 2011 Aug; 85(16):8208-16. PubMed ID: 21680517
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.
Facciuto F; Bugnon Valdano M; Marziali F; Massimi P; Banks L; Cavatorta AL; Gardiol D
Mol Oncol; 2014 May; 8(3):533-43. PubMed ID: 24462519
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
11. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
12. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes.
Narisawa-Saito M; Handa K; Yugawa T; Ohno S; Fujita M; Kiyono T
Oncogene; 2007 May; 26(21):2988-96. PubMed ID: 17146442
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
Shai A; Brake T; Somoza C; Lambert PF
Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103
[TBL] [Abstract][Full Text] [Related]
14. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
Lathion S; Schaper J; Beard P; Raj K
Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
16. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.
Handa K; Yugawa T; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
J Virol; 2007 Feb; 81(3):1379-89. PubMed ID: 17121805
[TBL] [Abstract][Full Text] [Related]
17. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
Berger KL; Barriga F; Lace MJ; Turek LP; Zamba GJ; Domann FE; Lee JH; Klingelhutz AJ
Virology; 2006 Dec 5-20; 356(1-2):68-78. PubMed ID: 16945398
[TBL] [Abstract][Full Text] [Related]
18. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.
Nguyen ML; Nguyen MM; Lee D; Griep AE; Lambert PF
J Virol; 2003 Jun; 77(12):6957-64. PubMed ID: 12768014
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
